Navigation Links
Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
Date:11/7/2011

NEW YORK, Nov. 7, 2011 /PRNewswire/ -- Delcath Systems (NASDAQ: DCTH) today reported financial results for the fiscal 2011 third quarter ended September 30, 2011.  Highlights for the quarter and recent developments include:

  • Research & Development:  Accelerated development of Generation Two of the Delcath Hepatic CHEMOSAT® Delivery system, which has demonstrated significantly higher filtration efficiency of melphalan in pre-clinical testing compared to Generation One of the system.
  • European Commercialization: Submission of CE Mark application for high-efficiency filter of Generation Two CHEMOSAT system, and earlier than anticipated availability of Generation Two for initial launch in European markets in early Q1 2012, subject to CE Mark approval.
  • Establishment of European Business Entity & Headquarters: Formation of Delcath Systems Ltd. (Delcath Limited), an Irish company headquartered in Galway, Ireland, under which Delcath will conduct its European operations. Delcath Limited received a development grant from IDA Ireland to support the hiring of staff over the next three years.
  • U.S. Regulatory:  Pre-New Drug Application (NDA) meeting scheduled with U.S. Food and Drug Administration (FDA) for mid-January 2012.
  • International Regulatory:  Completion of product notification process for CHEMOSAT with the Medicines and Medical Device Safety Authority in New Zealand, and submission of applications to obtain regulatory approval for CHEMOSAT for several other markets including Australia, Singapore and Hong Kong. The Company also submitted an application to obtain European CE Mark approval for the Generation Two high efficiency filter.
  • Clinical Trial Data Update: Updated efficacy results from the Company's Phase 3 trial showed the potential for CHEMOSAT as a promising
    '/>"/>

  • SOURCE Delcath Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
    2. FDA Schedules Delcath Pre-New Drug Application Meeting Date
    3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
    4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
    5. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
    6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
    7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
    8. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
    9. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
    10. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
    11. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Bridgewater, New Jersey location received ... Administration (FDA) relating to an inspection in June 2014 ... injectable, which was divested to Galderma S.A. in July ... contract manufacturers (rather than Valeant,s own internal manufacturing) with ...
    (Date:9/30/2014)... -- The Eastern European medical device industry is in ... as new medical-device manufacturers are constantly trying to penetrate ... to reduce the cost incurred for placing their products ... effective means to achieve this target. This research service ... and provides profiles of key distributors in ...
    (Date:9/30/2014)... , Sept. 30, 2014   Decision ... patient-level claims data, anemic chronic kidney disease non-dialysis ... erythropoiesis-stimulating agent (ESA) medication. In addition, one-year persistency ... Other key findings from the ... An Analysis of Erythropoiesis Stimulating Agents in Late ...
    Breaking Medicine Technology:Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
    ... On Friday, April 20, 2012, at 8:30 a.m. Eastern/2:30 ... Inc.,s (CTI) (NASDAQ and MTA: CTIC) management team will ... first quarter achievements and financial results. ... Central European/5:30 a.m. Pacific Time 1-800-762-8779 (US Participants) ...
    ... 2012  Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... version of FORTAMET® (metformin hydrochloride extended-release tablets) as part ... the product today. FORTAMET® is indicated as an adjunct ... patients 17 years of age or older. ...
    Cached Medicine Technology:Watson Launches Generic FORTAMET(R) 2
    (Date:9/30/2014)... some stickleback fish fathers can have long-term effects on ... dads cause their offspring to behave in a way ... changes are accompanied by changes in gene expression, the ... the Proceedings of the Royal Society B: Biological ... moms are very important for their offspring," said ...
    (Date:9/30/2014)... Asheville, North Carolina (PRWEB) September 30, 2014 ... cloud readiness and IT Infrastructure analytics across data ... announced it has achieved an important milestone of ... problems and plan for important projects such as ... workload migrations. , The strong customer engagement ...
    (Date:9/30/2014)... 2014 Speaking on this occasion, ... ‘Nursing Conference’ as a remarkable event, which brings together ... and clinical research and diagnostic companies, leading universities and ... perfect platform to share experience, foster collaborations across industry ... Nursing Conference is a forum to explore issues of ...
    (Date:9/30/2014)... 2014 MyMobileUni seeks to partner globally ... have similar shared vision to transform individuals and empower ... (MMU):, , to impact ... all ages , to have focused channels ... to promote equal access to education and ...
    (Date:9/30/2014)... with bowel cancer for a genetic condition would cut ... new research has found. , In a major study, ... and researchers from the University of Exeter,s Medical School ... for a genetic condition known as Lynch Syndrome. ... by changes in genes which check the spelling in ...
    Breaking Medicine News(10 mins):Health News:In stickleback fish, dads influence offspring behavior and gene expression 2Health News:In stickleback fish, dads influence offspring behavior and gene expression 3Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 3Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 2Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 3Health News:Genetic test would help 'cut bowel cancer spread' 2Health News:Genetic test would help 'cut bowel cancer spread' 3
    ... one species of bacteria could be more persistent and ... other, encouraging it to bolster its defenses. Interrupting ... these infections. Researchers from Wake Forest University Baptist ... , the online open-access journal of the American Society ...
    ... ... Boise, Idaho acupuncture clinic, recently relocated to a larger office and more convenient ... acupuncture clinic is now located in very close proximity to one of the ... licensed acupuncturists and 2 massage therapists working collaboratively to help patients get and ...
    ... 2010 Elsevier, the world-leading publisher of scientific, technical ... Society of Geriatric Oncology (SIOG) announced today the launch ... www.geriatriconcology.net ). The journal is focused on advancing ... of older adults with cancer. It covers all ...
    ... ... health care organizations better comply with OASIS-C and improve staff performance and patient outcomes ... new and updated patient and caregiver teaching resources. , ... (PRWEB) July 6, 2010 -- Pritchett & Hull ...
    ... Site ... ... Surgery (ASAPS) is proud to introduce Project Beauty , a new consumer website, that ... one the leading medical authorities in Beauty - The American Society for Aesthetic Plastic Surgery., , ...
    ... ... Though Advanced Software Testing Services and Methodologies , ... Naples, FL (PRWEB) July 6, 2010 -- QualEDIx, a ... ICD-10 software testing services network is pleased to announce that healthcare industry veteran, Larry ...
    Cached Medicine News:Health News:Bacterial communication encourages chronic, resistant ear infections 2Health News:Boise Acupuncture Clinic Grows into Larger Office 2Health News:Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology 2Health News:Aesthetic Society Launches Project Beauty, ,NEW Consumer Website Covering All Things Beauty, 2Health News:Aesthetic Society Launches Project Beauty, ,NEW Consumer Website Covering All Things Beauty, 3Health News:Larry Watkins Joins QualEDIx as Executive Vice President, Healthcare Strategy and Business Development 2Health News:Larry Watkins Joins QualEDIx as Executive Vice President, Healthcare Strategy and Business Development 3
    This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
    ... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
    This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
    Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
    Medicine Products: